↓ Skip to main content

Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients

Overview of attention for article published in Frontiers in Medicine, October 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients
Published in
Frontiers in Medicine, October 2023
DOI 10.3389/fmed.2023.1215916
Pubmed ID
Authors

Sávio Bastos de Souza, Paula Gebe Abreu Cabral, Renato Martins da Silva, Raul Ferraz Arruda, Sheila Passos de Figueiredo Cabral, Arícia Leone Evangelista Monteiro de Assis, Antônio Brazil Viana, Wim Maurits Sylvain Degrave, Aline dos Santos Moreira, Cléber Glória Silva, Junbiao Chang, Pingsheng Lei

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 20%
Professor 1 20%
Librarian 1 20%
Student > Ph. D. Student 1 20%
Unknown 1 20%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 1 20%
Mathematics 1 20%
Agricultural and Biological Sciences 1 20%
Chemistry 1 20%
Unknown 1 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2023.
All research outputs
#20,066,854
of 24,664,952 outputs
Outputs from Frontiers in Medicine
#4,753
of 6,779 outputs
Outputs of similar age
#115,683
of 171,353 outputs
Outputs of similar age from Frontiers in Medicine
#49
of 114 outputs
Altmetric has tracked 24,664,952 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,779 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,353 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.